JUNE 16-17 2020
VIRTUAL EVENT
PRECISION: BREAST CANCER
Click 'Register' to be directed to our virtual event page.
REGISTER
DOWNLOAD AGENDA
SCOPE OF THE MEETING
An exclusive, annual biopharma summit providing insights into the research and development of cutting edge treatments for Breast Cancer and a networking forum for precision medicine leaders in this space. From therapeutics to Diagnostics.
Breast Cancer is the most commonly occurring cancer in women, and is also the second leading cause of cancer death.
Breast cancer R&D receives the largest amount of spending across all cancer types, and represents the largest opportunity for developers.
The global market for breast cancer diagnostic and drug technologies reached $22.3 billion in 2014 and is expected to reach $27 billion in 2019.
Do You Have the Right R&D Strategies in Place?
Precision: Breast Cancer brings together scientists and business leaders from pharma, biotech and academia, using extensive networking sessions to forge meaningful collaborations.
Discussions are based around the latest trends in personalized medicine, using case studies covering early discovery to clinical development.
HIGHLIGHTS
ANTIBODY DRUG CONJUGATES
IMMUNOTHERAPY
LIQUID BIOPSY
COMPANION DIAGNOSTICS
NOVEL R&D APPROACHES
32%
26%
14%
12%
9%
7%
Large Drug Developers
Small & Mid-Sized Developers
Academia
& Hospitals
CROs &
Platform Technology
Equipment
Providers
Other
COMPANY TYPE
%
JOB TITLE
%
VP, Director, Head
C-Level
Scientists
Managers
48%
23%
18%
11%
GOALS OF THE EVENT
Learning Objectives
Target Audience
PRESENTATIONS
Past Presentations
April 24, 2019
ZW49: Combining the Azymetric and ZymeLink platforms to expand the therapeutic window of a bispecific HER2-targeting ADC
Rupert Davies
Principal Scientist, Oncology
Zymeworks
Novel Antibody Constructs
April 24. 2019
Sacituzumab Govitecan: Scientific rationale and clinical development in breast cancer
Martin Olivo
VP, Clinical Development
Immunomedics
Antibody Drug Conjugates
April 24, 2019
Imprime PGG, a novel Dectin Receptor agonist, in combination with pembrolizumab for metastatic TNBC
Jeremy Graff
President, CSO
Biothera
Immuno-Oncology
Immuno-Oncology
April 24, 2019
Immunotherapy in Breast Cancer: Moving forward
Dimitrios Zardavas
ProgramLead, Breast Cancer
Bristol-Myers Squibb
Immuno-Oncology
April 25, 2019
Liquid Biopsies: Enabling Precision Medicine
Jonathan Beer
Director, Lead of Disruptive Technologies
Novartis
Biomarkers
Companion Dx
April 25, 2019
B-cell profiling from patients to discern novel public targets for breast cancer therapeutics
Amy Manning-Bog
Senior Director, Translational Science
Atreca
Novel Approaches
VIEW FULL AGENDA
SPEAKERS
Past Speakers
SARAH WANG
Principal Scientist, Translational R&D
TESARO
ALEX LAZAR
Director, Analytical & Pharmaceutical Sciences
Immunogen
MARTIN OLIVO
VP, Clinical Development
Immunomedics
OMAR AHMAD
Principal Scientist
Pfizer
AL LALANI
SVP Translational Medicine
Puma Biotechnology
PETAR JELINIC
Director, Onc. Translational Sci
Merck
SANDRA DUNN
CEO
Phoenix Molecular
DAN STETSON
Associate Principal Scientist
AstraZeneca
VIEW FULL AGENDA
DOWNLOAD PDF
DOWNLOAD OUR EVENT GUIDE
7 Pages Of Content, Produced In Collaboration With Our Advisory Board
TICKET OPTIONS
Choose The Correct Ticket - Group Rates Available
INDUSTRY DELEGATE
Access to 2-day Conference & Networking Sessions
Pharma & Biotech Drug Developers / Solution Providers.
$2,199
(Limited Availability)
BUY NOW
ACADEMIC DELEGATE
Access to 2-day Conference & Networking Sessions
Reserved for Non-Profit Organizations.
$799
(Limited Availability)
BUY NOW
SPONSORS
Our Event is kindly supported by:
MEDIA PARTNERS
Our Event is Kindly Supported By:
VIEW MEDIA PARTNERS
PREVIOUS EVENTS
VENUE
Our Event is Hosted At:
Courtyard by Marriott Boston Downtown
275 Tremont St, Boston, MA 02116, USA
CONNECT!
Follow Our Latest News on Twitter
DOWNLOAD EVENT GUIDE
Complete the form below to download the PDF
NEO SYNTH International House, 24 Holborn Viaduct, London EC1A 2BN
contact@neo-synth.com
(+1) 617.500.5172
Your details will not be shared with a third party
Copyright © 2016 | All content produced by: neo-synth ltd.